PTGS2 and chronic obstructive pulmonary disease: Given the pivotal role of PKCs in airway diseases, particularly asthma and COPD [25], we investigated their involvement in SiNPs-induced COX-2 expression in HTSMCs using the selective PKCα inhibitor, Gö6976.